These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34875346)
1. ICAM-1 protects neurons against Amyloid-β and improves cognitive behaviors in 5xFAD mice by inhibiting NF-κB. Guha S; Paidi RK; Goswami S; Saha P; Biswas SC Brain Behav Immun; 2022 Feb; 100():194-210. PubMed ID: 34875346 [TBL] [Abstract][Full Text] [Related]
2. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Devi L; Ohno M Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928 [TBL] [Abstract][Full Text] [Related]
3. TIMP-1: A key cytokine released from activated astrocytes protects neurons and ameliorates cognitive behaviours in a rodent model of Alzheimer's disease. Saha P; Sarkar S; Paidi RK; Biswas SC Brain Behav Immun; 2020 Jul; 87():804-819. PubMed ID: 32194232 [TBL] [Abstract][Full Text] [Related]
4. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease. Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599 [TBL] [Abstract][Full Text] [Related]
5. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
6. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling. Park R; Kook SY; Park JC; Mook-Jung I Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961 [TBL] [Abstract][Full Text] [Related]
7. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease. Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234 [TBL] [Abstract][Full Text] [Related]
8. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease. Maiti P; Paladugu L; Dunbar GL BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781 [TBL] [Abstract][Full Text] [Related]
9. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease. Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216 [TBL] [Abstract][Full Text] [Related]
10. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse. Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912 [TBL] [Abstract][Full Text] [Related]
11. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ Jin S; Wang X; Xiang X; Wu Y; Hu J; Li Y; Lin Dong Y; Tan Y; Wu X Int Immunopharmacol; 2021 Dec; 101(Pt B):108335. PubMed ID: 34781121 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156 [TBL] [Abstract][Full Text] [Related]
14. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease. Paouri E; Tzara O; Zenelak S; Georgopoulos S J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177 [TBL] [Abstract][Full Text] [Related]
15. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling. Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954 [TBL] [Abstract][Full Text] [Related]
16. Oral Administration of Alpha Linoleic Acid Rescues Aβ-Induced Glia-Mediated Neuroinflammation and Cognitive Dysfunction in C57BL/6N Mice. Ali W; Ikram M; Park HY; Jo MG; Ullah R; Ahmad S; Abid NB; Kim MO Cells; 2020 Mar; 9(3):. PubMed ID: 32182943 [TBL] [Abstract][Full Text] [Related]
17. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease. Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223 [TBL] [Abstract][Full Text] [Related]
19. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173 [TBL] [Abstract][Full Text] [Related]
20. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]